News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Melanoma clinical trial ME17 is officially open for enrollment in Canada – Canadian Cancer Trials Group
Canadian Cancer Trials Group/LinkedIn
Jan 28, 2025, 17:20

Melanoma clinical trial ME17 is officially open for enrollment in Canada – Canadian Cancer Trials Group

Canadian Cancer Trials Group shared a post on LinkedIn:

“Melanoma clinical trial ME17 is officially open for enrollment in Canada. The study will compare immunotherapy alone with adding FMT treatment to the immunotherapy to improve outcomes.

Learn more.”

Canadian Cancer Trials Group cancer ME17 Melanoma OncoDaily Oncology
Special Coverage
Drugs
Mar 6, 2025, 12:21
Zolbetuximab: Uses in Cancer, Side Effects, Dosages, Expectations, and More
Blog
Mar 6, 2025, 12:16
Stephen V Liu: Houda Bahig on the role of radiation in the era of perioperative immunotherapy for NSCLC
Science
Mar 6, 2025, 10:57
Armando Orlandi: NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemotherapy
Science
Mar 6, 2025, 10:44
Adam B. Weiner: SBRT and ADT for oligometastatic prostate cancer
Blog
Mar 6, 2025, 10:40
ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy
Science
Mar 6, 2025, 10:30
Myeloma Paper of the Day, March 6th, suggested by Robert Orlowski
Science
Mar 6, 2025, 10:22
Yuji Uehara: TKIs for non-small cell lung cancer with EGFR exon 19 insertions
Blog
Mar 6, 2025, 10:13
Nina Niu Sanford: Rectal cancer 101 video
Blog
Mar 6, 2025, 10:09
Last Call to register to the SurNet Webinar - Childhood Cancer International
Insight
Mar 6, 2025, 10:00
Applonia Rose: TCRT's impactful review articles on colorectal cancer
Blog
Mar 6, 2025, 09:56
Dégi László Csaba: A message of hope and unity in the fight against cancer
Science
Mar 6, 2025, 09:52
Gilberto Lopes: Revolutionising cancer treatment access MICS